This page shows the publications Nolan Priedigkeit has written about Antineoplastic Agents, Hormonal.
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer. Ann Oncol. 2018 04 01; 29(4):872-880.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.